A Study of Persistent Post-Concussion Symptoms in Mild Head Trauma Using Positron Emission Tomogrophy
JNNP 74:326-332, Chen,S.H.A.,et al, 2003
Assessing Tissue Viability with MR Diffusion and Perfusion Imaging
AJNR 24:436-443, Schaefer,P.W.,et al, 2003
MR Imaging of Autopsy-Proved Paraneoplastic Limbic Encephalitis in Non-Hodgkin Lymphoma
AJNR 24:507-511, Thuerl,C.,et al, 2003
Mass Lesions of the Brain in AIDS: The Dilemmas of Distinguishing Toxoplasmosis from Primary CNS Lymphoma
AJNR 24:554-555, Berger,J.R., 2003
Safety and Feasibility of a CT Protocol for Acute Stroke: Combined CT, CT Angiography, and CT Perfusion Imaging in 53 Consecutive Patients
AJNR 24:688-690, Smith,W.S.,et al, 2003
Secondary Prevention of Stroke in Italy
Stroke 34:1010-1014, Filippi,A.,et al, 2003
Palinopsia
Lancet 361:1098, Smith,P.E.M.,et al, 2003
Blood Pressure-Lowering for Secondary Prevention of Stroke: ACE Inhibition Is Not the Key
Stroke 34:1334-1335,1335, Bath,P., 2003
Blood Pressure--Lowering for Secondary Prevention of Stroke: ACE Inhibition Is the Key
Stroke 34:1333-1334,1334, Anderson,C., 2003
Takayasu's Arteritis with Arteriographic Evidence of Intracranial Vessel Involvement
Neurol 60:1550-1551, Klos,K.,et al, 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients
NEJM 348:2196-2203, Iwamoto,M.,et al, 2003
Differentiation of Toxoplasmosis and Lymphoma in AIDS Patients by Using Apparent Diffusion Coefficients
AJNR 24:633-637,554, Camacho,D.L.A.,et al, 2003
Differences in the Diagnostic Accuracy of Acute Stroke Clinical Subtypes Defined by Multimodal Magnetic Resonance Imaging
JNNP 74:886-888,840, Allder,S.J.,et al, 2003
Major Risk Factors for Aneurysmal Subarrachnoid Hemorrhage in the Young are Modifiable
Stroke 34:1375-1381, Broderick,J.P.,et al, 2003
Non-Aneurysmal Primary Subarachnoid Hemorrhage in Pregnancy-Induced Hypertension and Eclampsia
Neurol 61:117-120, Shah,A.K., 2003
Stroke Associated with Sympathomimetics Contained in Over-the Counter Cough and Cold Drugs
Stroke 34:1667-1673, Cantu,C.,et al, 2003
Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch
Stroke 34:1681-1685, Coutts,S.B.,et al, 2003
Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07
J Clin Oncol 21:1044-1049, Batchelor,T.,et al, 2003
Risk Factors for intracerebral Hemorrhage in the General Population
Stroke 34:2060-2066, Ariesen,M.J.,et al, 2003
Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion- Weighted Magnetic Resonance Imaging
Stroke 34:1892-1900, Thomalla,G.J.,et al, 2003
Medullary Streaks: Dilated Medullary Vessels in Chronic Ischemia in Children
Neurol 61:583-584, Takanashi,J.,et al, 2003
Vascular Syndromes of the Thalamus
Stroke 34:2264-2278, Schumahmann,J.D., 2003
A Case of Cortical Vein Thrombosis with the Cord Sign
Arch Neurol 60:1314-1316, Ahn,T-B &Roh,J-K, 2003
Beyond Mismatch
Stroke 34:2729-2735, Kidwell,C.S.,et al, 2003
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
Stroke 34:2741-2749, Rashid,P.,et al, 2003
Relationship Between Blood Pressure and Stroke Risk in Patients with Symptomatic Carotid Occlusive Disease
Stroke 34:2583-2592, Rothwell,P.M.,et al, 2003
Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003
Best Measure of Ischemic Penumbra: Positron Emission Tomography
Stroke 34:2534-2535, Heiss,W.-D., 2003
Measurement of the Ischemic Penumbra With MRI: It's About Time
Stroke 34:2533-2534, Warach,S., 2003
Detrminental Effect of Blood Pressure Reduction in the First 24 Hours of Acute Stroke Onset
Neurol 61:1047-1051,1030, Oliveira-Filho,J.,et al, 2003
Increased Risk of Stroke in Hypertensive Women Using Hormone Therapy
Arch Neurol 60:1379-1384, Lekkegaard,E.,et al, 2003
Evaluation of Hyperintense Vessels on FLAIR MRI for the Diagnosis of Multiple Intracerebral Arterial Stenoses
Stroke 34: 1886-1891, Iancu-Gontard,D.,et al, 2003
The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003
Primary Anaplastic Large Cell Lymphoma of the Central Nervous System
Am J Surg Pathol 27:487-493, George, D.H.,et al, 2003
Left Internal Carotid Artery Dissection Presenting with Headache, Collet-Sicard Syndrome and Sustained Hypertension
Eur J Neurol 10:731-732, Walker, S.,et al, 2003
Strokes Restricted to the Insular Cortex
Neurol 59:1950-1955, Cereda,C.,et al, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary Central Nervous System Lymphoma
Ann Neurol 51:247-252, Herrlinger,U.,et al, 2002
CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes
Neurol 58:390-396,339, Gleissner,B.,et al, 2002
The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia
Stroke 33:319-320, van Gijn,J., 2002
Acute Intravenou-Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Stroke 33:279-282, Hill,M.D.,et al, 2002
Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002
Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale
Stroke 33:706-711, Lamy,C.,et al, 2002
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Primary Sellar Lymphoma:Radiologic and Pathologic Findings in Two Patients
AJNR 23:364-367, Kaufmann,T.J.,et al, 2002
Clinicopath Conf, Primary Lymphoma of CNS
NEJM 346:1009-1015, Case 10-2002, 2002
A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002
First-line Therapy with Temozolomide Induces Regression of Primary CNS Lymphoma
Neurol 58:1573-1574, Herrlinger,U.,et al, 2002
Subarachnoid Hemorrhage
Stroke 33:1321-1326, Kissela,B.M.,et al, 2002
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002